Latest disclosed trades
Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.
See the tradesUpdated Oct 17 · 2 feeds behind: Insider filings, 4 days, and 1 more · Every feed →
KYMR · sells only · 190 trades
Trades
190
Buys 0 · Sells 190
People
15
Stocks
1
Disclosed value
$2B
range midpoints · Congress & executive
Filed late
3
- ▼ SELLBiotechnology Value Trading Fund OS LP DirectorKYMR Kymera Therapeutics, Inc.$66.8Mdisclosed Jun 26 · filed the same day
- ▼ SELLBiotechnology Value Fund II LP DirectorKYMR Kymera Therapeutics, Inc.$5.5Mdisclosed Jun 26 · filed the same day
- ▼ SELLBiotechnology Value Fund L P DirectorKYMR Kymera Therapeutics, Inc.$5.5Mdisclosed Jun 26 · filed the same day
- ▼ SELLBVF Partners OS Ltd. DirectorKYMR Kymera Therapeutics, Inc.$66.8Mdisclosed Jun 26 · filed the same day
- ▼ SELLMark N Lampert DirectorKYMR Kymera Therapeutics, Inc.$5.5Mdisclosed Jun 26 · filed the same day
- ▼ SELLBiotechnology Value Trading Fund OS LP DirectorKYMR Kymera Therapeutics, Inc.$5.5Mdisclosed Jun 26 · filed the same day
- ▼ SELLBiotechnology Value Trading Fund OS LP DirectorKYMR Kymera Therapeutics, Inc.$89.2Mdisclosed Jun 26 · filed the same day
- ▼ SELLBiotechnology Value Fund L P DirectorKYMR Kymera Therapeutics, Inc.$89.2Mdisclosed Jun 26 · filed the same day
- ▼ SELLBVF Partners OS Ltd. DirectorKYMR Kymera Therapeutics, Inc.$5.5Mdisclosed Jun 26 · filed the same day
- ▼ SELLInc/il Bvf DirectorKYMR Kymera Therapeutics, Inc.$5.5Mdisclosed Jun 26 · filed the same day
- ▼ SELLMark N Lampert DirectorKYMR Kymera Therapeutics, Inc.$12.1Mdisclosed Jun 26 · filed the same day
- ▼ SELLMark N Lampert DirectorKYMR Kymera Therapeutics, Inc.$66.8Mdisclosed Jun 26 · filed the same day
- ▼ SELLBvf II GP LLC DirectorKYMR Kymera Therapeutics, Inc.$89.2Mdisclosed Jun 26 · filed the same day
- ▼ SELLBiotechnology Value Fund II LP DirectorKYMR Kymera Therapeutics, Inc.$12.1Mdisclosed Jun 26 · filed the same day
- ▼ SELLBiotechnology Value Fund II LP DirectorKYMR Kymera Therapeutics, Inc.$89.2Mdisclosed Jun 26 · filed the same day
- ▼ SELLBvf II GP LLC DirectorKYMR Kymera Therapeutics, Inc.$12.1Mdisclosed Jun 26 · filed the same day
- ▼ SELLBiotechnology Value Trading Fund OS LP DirectorKYMR Kymera Therapeutics, Inc.$12.1Mdisclosed Jun 26 · filed the same day
- ▼ SELLBvf I GP LLC DirectorKYMR Kymera Therapeutics, Inc.$5.5Mdisclosed Jun 26 · filed the same day
- ▼ SELLBvf GP Holdings LLC DirectorKYMR Kymera Therapeutics, Inc.$89.2Mdisclosed Jun 26 · filed the same day
- ▼ SELLBVF Partners OS Ltd. DirectorKYMR Kymera Therapeutics, Inc.$12.1Mdisclosed Jun 26 · filed the same day
- ▼ SELLBvf GP Holdings LLC DirectorKYMR Kymera Therapeutics, Inc.$12.1Mdisclosed Jun 26 · filed the same day
- ▼ SELLBiotechnology Value Fund L P DirectorKYMR Kymera Therapeutics, Inc.$12.1Mdisclosed Jun 26 · filed the same day
- ▼ SELLInc/il Bvf DirectorKYMR Kymera Therapeutics, Inc.$66.8Mdisclosed Jun 26 · filed the same day
- ▼ SELLBvf II GP LLC DirectorKYMR Kymera Therapeutics, Inc.$66.8Mdisclosed Jun 26 · filed the same day
- ▼ SELLBiotechnology Value Fund II LP DirectorKYMR Kymera Therapeutics, Inc.$66.8Mdisclosed Jun 26 · filed the same day